Efficacy of Apremilast in Patients With Moderate-to-Severe Genital Psoriasis: Body Surface Area Subgroup Results from the Phase 3 DISCREET Trial. J of Skin 2023, 7 (6), s255. https://doi.org/10.25251/skin.7.supp.255.